HB 625 Virginia House of Delegates · 2026 Regular Session

Health insurance; limit on cost-sharing payments for prescription drugs under certain plans.

Summary
Health insurance; limit on cost-sharing payments for prescription drugs under certain plans. Requires each carrier that offers a health plan in either the individual or small group market to ensure that at least one health plan in each of the bronze, silver, gold, and platinum levels of coverage in each rating area in the individual and small group market conform with the following: (i) a plan that offers a platinum level of coverage shall limit a person's cost-sharing payment for prescription drugs covered under the plan to an amount that does not exceed $150 per 30-day supply of the prescription drug; (ii) a plan that offers a gold level of coverage shall limit a person's cost-sharing payment for prescription drugs covered under the plan to an amount that does not exceed $200 per 30-day supply of the prescription drug; (iii) a plan that offers a silver level of coverage shall limit a person's cost-sharing payment for prescription drugs covered under the plan to an amount that does not exceed $250 per 30-day supply of the prescription drug; and (iv) a plan that offers a bronze level of coverage shall limit a person's cost-sharing payment for prescription drugs covered under the plan to an amount that does not exceed $300 per 30-day supply of the prescription drug. The bill requires that any plans offered to meet its requirements are (a) clearly and appropriately named to aid the consumer or plan sponsor in the plan selection process and (b) marketed in the same manner as other plans offered by the carrier. The bill's provisions apply to any individual or group accident and sickness insurance policy, any individual or group accident and sickness subscription contract, and any health care plan for health care services delivered, issued for delivery, or renewed in the Commonwealth on or after January 1, 2028. This bill is identical to SB 161.
Bill status signed all 5 stages cleared
Introduction
Jan 2026
Committee Review
Mar 2026
House of Delegates Passage
Mar 2026
Senate Passage
Mar 2026
Signed into Law
Apr 2026
Introduced Jan 13, 2026 Signed Apr 13, 2026
Maddy AI version diff · 4 comparisons

What changed between versions

Enrolled Chaptered · 1 edit
MINOR
The bill was finalized and assigned Chapter 641, with the approval date updated to April 13, 2026. The core policy content regarding the limit on cost-sharing payments for prescription drugs remains unchanged.
Scope change
The bill's scope and applicability remain unchanged; only the finalization details were updated.
TIMELINE

The approval date was updated to April 13, 2026, and the session header was changed to reflect the final enrolled status.

Floor votes · Senate Feb 25, 2026 · House of Delegates Feb 11, 2026

How they voted

390
Passed
Total votes 39
Feb 25, 2026
D Democratic20
20 Yea
100% Yea
R Republican19
19 Yea
100% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
44
Key actions
14
Committee
11
Amendments
3
Apr 13, 2026
Signed into law
Approved by Governor-Chapter 641 (effective 7/1/2026)
executive
Mar 31, 2026
Lower · Passed
Signed by Speaker
lower
Mar 30, 2026
Upper · Passed
Signed by President
upper
Mar 30, 2026
Lower · Passed
Bill text as passed House and Senate (HB625ER)
lower
Mar 11, 2026
Upper · Passed
Conference report agreed to by Senate (39-Y 0-N 0-A)
upper
Mar 10, 2026
Lower · Passed
Conference report agreed to by House (63-Y 33-N 0-A)
lower
Mar 10, 2026
Legislature · Passed
Conference Report released
legislature
Mar 4, 2026
Committee
Senate requested conference committee
upper
Mar 4, 2026
Introduced
Senate insisted on amendment (40-Y 0-N 0-A)
upper
Feb 26, 2026
Upper · Passed
Passed Senate with substitute (37-Y 3-N 0-A)
upper
Feb 25, 2026
Upper · Passed
Passed by for the day Block Vote (Voice Vote)
upper
Feb 23, 2026
Upper · Passed
Reported from Commerce and Labor with substitute (11-Y 4-N)
upper
Feb 12, 2026
Committee
Referred to Committee on Commerce and Labor
upper
Feb 11, 2026
Lower · Passed
Read third time and passed House (63-Y 35-N 0-A)
lower
Feb 10, 2026
Introduced
Engrossed by House as amended
lower
Feb 10, 2026
Lower · Passed
committee amendment agreed to
lower
Feb 5, 2026
Lower · Passed
Reported from Labor and Commerce with amendment(s) (15-Y 7-N)
lower
Feb 3, 2026
Lower · Passed
Subcommittee recommends reporting with amendment(s) (6-Y 3-N)
lower
Feb 3, 2026
Committee
Subcommittee failed to recommend reporting (4-Y 5-N)
lower
Jan 20, 2026
Committee
Assigned HCL sub: Subcommittee #1
lower
Jan 13, 2026
Committee
Referred to Committee on Labor and Commerce
lower
1 primary · 1 co-sponsor

Sponsors